• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替考拉宁在社区医疗中的应用。

Use of teicoplanin in community medicine.

作者信息

Wilson A P, Grüneberg R N

机构信息

Department of Clinical Microbiology, University College Hospital, London, UK.

出版信息

Eur J Clin Microbiol Infect Dis. 1994 Sep;13(9):701-10. doi: 10.1007/BF02276052.

DOI:10.1007/BF02276052
PMID:7843174
Abstract

Administration of parenteral antibiotics to outpatients is increasingly used to reduce hospital costs, to reduce loss of earnings for the patient and to improve the quality of life in patients requiring prolonged antibiotic treatment. The glycopeptides are required for treatment of infections caused by methicillin resistant staphylococci and some enterococci, or for treatment of patients allergic to beta-lactam agents. For home therapy, teicoplanin has some advantages over vancomycin in that it requires only once-daily bolus administration, does not necessitate monitoring of serum concentrations and offers the choice of intravenous or intramuscular administration. Teicoplanin has been used to complete treatment of endocarditis at home in selected patients, streptococcal disease being the most suitable form of endocarditis for this treatment. In open trials, teicoplanin has been found effective in home therapy of osteomyelitis but, as with other agents, prolonged dosage can be associated with adverse effects. It has also been used for home treatment of infections of the respiratory tract, intravascular catheters and soft tissue. Despite its higher acquisition costs, teicoplanin is to be preferred over vancomycin because of the reduced administration and assay costs and fewer adverse effects.

摘要

门诊患者使用胃肠外抗生素越来越多地用于降低医院成本、减少患者收入损失以及提高需要长期抗生素治疗患者的生活质量。糖肽类药物用于治疗耐甲氧西林葡萄球菌和某些肠球菌引起的感染,或用于治疗对β-内酰胺类药物过敏的患者。对于家庭治疗,替考拉宁比万古霉素有一些优势,因为它只需每日一次大剂量给药,无需监测血清浓度,并且提供静脉或肌肉注射的选择。替考拉宁已用于在选定患者家中完成心内膜炎的治疗,链球菌病是最适合这种治疗的心内膜炎形式。在开放试验中,已发现替考拉宁在家中治疗骨髓炎有效,但与其他药物一样,长期用药可能会有不良反应。它也已用于呼吸道、血管内导管和软组织感染的家庭治疗。尽管其购置成本较高,但由于给药和检测成本降低以及不良反应较少,替考拉宁比万古霉素更可取。

相似文献

1
Use of teicoplanin in community medicine.替考拉宁在社区医疗中的应用。
Eur J Clin Microbiol Infect Dis. 1994 Sep;13(9):701-10. doi: 10.1007/BF02276052.
2
Teicoplanin in the treatment of serious infection.替考拉宁治疗严重感染。
J Chemother. 2000 Nov;12 Suppl 5:26-33. doi: 10.1080/1120009x.2000.11782315.
3
Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.替考拉宁:对其用于治疗革兰氏阳性菌感染的药物经济学评价
Pharmacoeconomics. 1995 Apr;7(4):357-74. doi: 10.2165/00019053-199507040-00009.
4
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.比较替考拉宁和万古霉素作为中性粒细胞减少患者感染二线经验性治疗的成本效益的随机前瞻性研究。
Haematologica. 1999 Mar;84(3):231-6.
5
Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.替考拉宁治疗骨与关节感染。美国替考拉宁骨与关节合作研究组
Eur J Surg Suppl. 1992(567):9-13.
6
Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.替考拉宁:抗菌活性、药代动力学特性及治疗潜力综述
Drugs. 1990 Sep;40(3):449-86. doi: 10.2165/00003495-199040030-00007.
7
Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.利奈唑胺与替考拉宁治疗重症患者革兰氏阳性菌感染的随机、双盲、多中心研究。
J Antimicrob Chemother. 2004 Feb;53(2):345-55. doi: 10.1093/jac/dkh048. Epub 2004 Jan 7.
8
[Pharmacological considerations in the economic evaluation of glycopeptides].[糖肽类药物经济学评价中的药理学考量]
Rev Clin Esp. 1997 Sep;197 Suppl 2:68-73.
9
Management of serious staphylococcal infections in the outpatient setting.门诊环境中严重葡萄球菌感染的管理。
Drugs. 1997;54 Suppl 6:21-8. doi: 10.2165/00003495-199700546-00006.
10
Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.基于替考拉宁的抗菌疗法治疗金黄色葡萄球菌骨与关节感染:耐受性、疗效及皮下给药经验
BMC Infect Dis. 2016 Nov 3;16(1):622. doi: 10.1186/s12879-016-1955-7.

引用本文的文献

1
Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.胃肠外头孢菌素在门诊环境中的应用:临床证据
Drugs. 2000;59 Suppl 3:37-46; discussion 47-9. doi: 10.2165/00003495-200059003-00005.
2
Ambulatory use of parenteral antibacterials: contemporary perspectives.肠外抗菌药物的门诊使用:当代观点
Drugs. 2000;59 Suppl 3:1-8; discussion 47-9. doi: 10.2165/00003495-200059003-00001.
3
Rational prescribing of antibacterials in hospitalised children.住院儿童抗菌药物的合理处方

本文引用的文献

1
Cost implications of malpractice and adverse events.医疗事故和不良事件的成本影响。
Hosp Formul. 1993 Jan;28 Suppl 1:59-61.
2
The true cost of monitoring antibiotic levels.
Hosp Formul. 1993 Jan;28 Suppl 1:55-8.
3
Impact of nosocomial infections on hospital costs.医院感染对医院成本的影响。
Hosp Formul. 1993 Jan;28 Suppl 1:51-4.
Pharmacoeconomics. 1996 Dec;10(6):575-93. doi: 10.2165/00019053-199610060-00005.
4
Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.替考拉宁:对其用于治疗革兰氏阳性菌感染的药物经济学评价
Pharmacoeconomics. 1995 Apr;7(4):357-74. doi: 10.2165/00019053-199507040-00009.
5
A survey of the use of teicoplanin in patients with haematological malignancies and solid tumours.一项关于替考拉宁在血液系统恶性肿瘤和实体瘤患者中应用情况的调查。
Infection. 1998 Nov-Dec;26(6):389-95. doi: 10.1007/BF02770842.
6
Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis?清洁手术中的耐甲氧西林葡萄球菌。预防性用药有作用吗?
Drugs. 1997;54 Suppl 6:39-52. doi: 10.2165/00003495-199700546-00008.
7
Anti-gram-positive agents. What we have and what we would like.抗革兰氏阳性菌药物。我们现有的和我们想要的。
Drugs. 1997;54 Suppl 6:29-38. doi: 10.2165/00003495-199700546-00007.
8
Management of serious staphylococcal infections in the outpatient setting.门诊环境中严重葡萄球菌感染的管理。
Drugs. 1997;54 Suppl 6:21-8. doi: 10.2165/00003495-199700546-00006.
9
Successful single-dose teicoplanin prophylaxis against experimental streptococcal, enterococcal, and staphylococcal aortic valve endocarditis.单剂量替考拉宁预防实验性链球菌、肠球菌和葡萄球菌性主动脉瓣心内膜炎成功。
Antimicrob Agents Chemother. 1997 Sep;41(9):1916-21. doi: 10.1128/AAC.41.9.1916.
10
A risk-benefit assessment of teicoplanin in the treatment of infections.替考拉宁治疗感染的风险效益评估。
Drug Saf. 1995 Nov;13(5):317-28. doi: 10.2165/00002018-199513050-00005.
4
Cost implications of home care on serious infections.
Hosp Formul. 1993 Jan;28 Suppl 1:46-50.
5
Treating bone and joint infections with teicoplanin: hospitalization vs outpatient cost issues.用替考拉宁治疗骨与关节感染:住院与门诊费用问题
Hosp Formul. 1993 Jan;28 Suppl 1:41-5.
6
Cost effectiveness of teicoplanin and ceftriaxone: a once-daily antibiotic regimen.替考拉宁和头孢曲松的成本效益:每日一次抗生素治疗方案
Hosp Formul. 1993 Jan;28 Suppl 1:20-2.
7
Teicoplanin in home therapy of the terminally ill child.
Eur J Haematol Suppl. 1993;54:14-7. doi: 10.1111/j.1600-0609.1993.tb01900.x.
8
The management of infections and antibiotic therapy: a European survey.
J Antimicrob Chemother. 1993 Jun;31(6):985-1000. doi: 10.1093/jac/31.6.985.
9
The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria.替考拉宁治疗革兰氏阳性菌引起的心内膜炎的疗效。
J Antimicrob Chemother. 1993 May;31(5):755-66. doi: 10.1093/jac/31.5.755.
10
Methicillin-resistant Staphylococcus aureus in Europe.欧洲的耐甲氧西林金黄色葡萄球菌
Eur J Clin Microbiol Infect Dis. 1994 Jan;13(1):50-5. doi: 10.1007/BF02026127.